LYEL

NASDAQ · Equity

Lyell Immunopharma Inc

US Healthcare Biotechnology

Latest week
29 May 2026
Close
17.330000
Fair value
27.801474
Expectation
Undecided 48.21%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
17.33
12-Week Change
-18.45%
Trend Signal
Inactive
Expectation
Undecided 48.21%
Signal Weeks
1 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-22.87
Market Dynamics
-1.11

Over the latest 12 completed weeks ending 2026-05-29, LYEL fell 18.45%, moving from 21.25 to 17.33. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 1 of the last 12 weeks. Relative Strength is -22.87 and has softened across the 12-week window. Market Dynamics is -1.11 on the latest week. Expectation is undecided at 48.21%.